» Articles » PMID: 17065350

Reduction of Diabetes-induced Oxidative Stress, Fibrotic Cytokine Expression, and Renal Dysfunction in Protein Kinase Cbeta-null Mice

Overview
Journal Diabetes
Specialty Endocrinology
Date 2006 Oct 27
PMID 17065350
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes induces the activation of several protein kinase C (PKC) isoforms in the renal glomeruli. We used PKC-beta(-/-) mice to examine the action of PKC-beta isoforms in diabetes-induced oxidative stress and renal injury at 8 and 24 weeks of disease. Diabetes increased PKC activity in renal cortex of wild-type mice and was significantly reduced (<50% of wild-type) in diabetic PKC-beta(-/-) mice. In wild-type mice, diabetes increased the translocation of PKC-alpha and -beta1 to the membrane, whereas only PKC-alpha was elevated in PKC-beta(-/-) mice. Increases in urinary isoprostane and 8-hydroxydeoxyguanosine, parameters of oxidative stress, in diabetic PKC-beta(-/-) mice were significantly reduced compared with diabetic wild-type mice. Diabetes increased NADPH oxidase activity and the expressions of p47(phox), Nox2, and Nox4 mRNA levels in the renal cortex and were unchanged in diabetic PKC-beta(-/-) mice. Increased expression of endothelin-1 (ET-1), vascular endothelial growth factor (VEGF), transforming growth factor (TGF)-beta, connective tissue growth factor (CTGF), and collagens IV and VI found in diabetic wild-type mice was attenuated in diabetic PKC-beta(-/-) mice. Diabetic PKC-beta(-/-) mice were protected from renal hypertrophy, glomerular enlargement, and hyperfiltration observed in diabetic wild-type mice and had less proteinuria. Lack of PKC-beta can protect against diabetes-induced renal dysfunction, fibrosis, and increased expressions of Nox2 and -4, ET-1, VEGF, TGF-beta, CTGF, and oxidant production.

Citing Articles

Oxidative Stress in Kidney Injury and Hypertension.

Arendshorst W, Vendrov A, Kumar N, Ganesh S, Madamanchi N Antioxidants (Basel). 2025; 13(12.

PMID: 39765782 PMC: 11672783. DOI: 10.3390/antiox13121454.


Does Adenosine Triphosphate via Purinergic Receptor Signalling Fuel Pulmonary Fibrosis?.

Forde L, Gogoi D, Baird R, McCarthy C, Keane M, Reeves E J Innate Immun. 2024; 17(1):44-55.

PMID: 39662078 PMC: 11779128. DOI: 10.1159/000543083.


Targeting NADPH Oxidase as an Approach for Diabetic Bladder Dysfunction.

Silveira T, Silva F, Hill W, Antunes E, de Oliveira M Antioxidants (Basel). 2024; 13(10).

PMID: 39456409 PMC: 11504422. DOI: 10.3390/antiox13101155.


Pathomechanisms of Diabetic Kidney Disease.

Sinha S, Nicholas S J Clin Med. 2023; 12(23).

PMID: 38068400 PMC: 10707303. DOI: 10.3390/jcm12237349.


A protein kinase C α and β inhibitor blunts hyperphagia to halt renal function decline and reduces adiposity in a rat model of obesity-driven type 2 diabetes.

Wang J, Casimiro-Garcia A, Johnson B, Duffen J, Cain M, Savary L Sci Rep. 2023; 13(1):16919.

PMID: 37805649 PMC: 10560236. DOI: 10.1038/s41598-023-43759-7.